Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
JHEP Reports : Innovation in Hepatology|March 18, 2021
A hepatitis B virus transgenic mouse model with a conditional, recombinant, episomal genomeRobert L Kruse, Mercedes Barzi, Xavier Legras, et al.Nature Communications|October 19, 2017
Erratum: A novel humanized mouse lacking murine p450 oxidoreductase for studying human drug metabolismMercedes Barzi, Francis P Pankowicz, Barry Zorman, et al.Nature Communications|June 30, 2017
A novel humanized mouse lacking murine P450 oxidoreductase for studying human drug metabolismMercedes Barzi, Francis P Pankowicz, Barry Zorman, et al.Cytotherapy|April 11, 2018
HBsAg-redirected T cells exhibit antiviral activity in HBV-infected human liver chimeric miceRobert L Kruse, Thomas Shum, Haruko Tashiro, et al.Molecular Therapy. Methods & Clinical Development|June 18, 2021
Targeting the Apoa1 locus for liver-directed gene therapyMarco De Giorgi, Ang Li, Ayrea Hurley, et al.Nature Communications|August 31, 2016
Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemiaFrancis P Pankowicz, Mercedes Barzi, Xavier Legras, et al.JHEP Reports : Innovation in Hepatology|April 11, 2025
CRISPR/Cas9 gene therapy increases the risk of tumorigenesis in the mouse model of hereditary tyrosinemia type ITong Chen, Mercedes Barzi, Nika Furey, et al.Gastroenterology|September 1, 2018
Rapid Disruption of Genes Specifically in Livers of Mice Using Multiplex CRISPR/Cas9 EditingFrancis P Pankowicz, Mercedes Barzi, Kang Ho Kim, et al.Hepatology Communications|April 26, 2024
Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1Ilayda Ates, Callie Stuart, Tanner Rathbone, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|November 17, 2021
Metabolism of a Selective Serotonin and Norepinephrine Reuptake Inhibitor Duloxetine in Liver Microsomes and MiceXuan Qin, John M Hakenjos, Kevin R MacKenzie, et al.Pageof 3